Acute Promyelocytic Leukemia
Links shared publicly online about this topic
Acute Promyelocytic Leukemia Therapy-New acute promyelocytic leukemia therap...
newsrx.com — “World's Largest Source of Health Information. Health, Medical, Biotech, Legal, Business & Clinical Research News for Professionals and Knowledgeable Consumers.” View full resource at newsrx.com
Most Recently Shared on May 28, 2009 at 1:01 pm By:
NewsRx Medical News Health News
New acute promyelocytic leukemia therapy research has been reported by scientists at...http://bit.ly/igQjf
Risk of acute promyelocytic leukemia in multiple sclerosis
neurology.org — “Risk of acute promyelocytic leukemia in multiple sclerosis” View full resource at neurology.org
Most Recently Shared on March 24, 2011 at 4:17 pm By:
Neurology Journal Medical Journal and Neurology
Risk of acute promyelocytic leukemia in multiple sclerosis: Coding variants of DNA repair genes http://bit.ly/hCJnCo #neurology
Pediatrics Medical News about acute promyelocytic leukemia
mdlinx.com — “Single-agent arsenic trioxide in the treatment of children with newly diagnosed acute promyelocytic leukemia” View full resource at mdlinx.com
Most Recently Shared on December 24, 2009 at 10:13 am By:
Sandeep Pulim MD Doctor, Health Communicator, and Physician
Peds: Single-agent arsenic trioxide in the treatment of children with newly diagnosed acute promyelocytic leukemia: Bloo http://url4.eu/yWUQ
Phase 2 study of tamibarotene for relapsed acute promyelocytic leukemia (APL) - MPR
empr.com — “CytRx Corporation announced favorable preliminary results from its Phase 2 STAR-1 registration clinical trial for tamibarotene in the treatment of acute promyelocytic leukemia (APL) in patients failing other treatments.” View full resource at empr.com
Most Recently Shared on December 7, 2009 at 7:32 pm By:
MPR News: Phase 2 study of tamibarotene for relapsed acute promyelocytic leukemia (APL): CytRx Corporation announce... http://bit.ly/6oQpIW
Cytrx's tamibarotene achieves molecular complete remission in advanced acute promyelocytic leukemia
news-medical.net — “CytRx Corporation, a biopharmaceutical company specializing in oncology, today announced that a 44-year-old female patient with advanced acute promyelocytic leukemia (APL) achieved molecular complete remission with no evidence of disease in the blood cells and/or bone marrow following treatment with CytRx's oncology drug candidate tamibarotene.” View full resource at news-medical.net
Most Recently Shared on July 23, 2010 at 7:42 am By:
Cytrx’s tamibarotene achieves molecular complete remission in advanced acute promyelocytic leukemia: CytRx Corpora... http://bit.ly/d4RlSv
Lack of clarity in the definition of treatment-related mortality: pediatric acute leukemia and adult acute promyelocytic leukemia as examples
bloodjournal.hematologylibrary.org — “Lack of clarity in the definition of treatment-related mortality: pediatric acute leukemia and adult acute promyelocytic leukemia as examples” View full resource at bloodjournal.hematologylibrary.org
Most Recently Shared on November 14, 2011 at 11:56 pm By:
Brandon Hayes-Lattin Doctor, Internist, Oncologist, and Physician
Another definition issue involving peds vs adults http://t.co/9vHxWndg
Early death rate in acute promyelocytic leukemia r... [Blood. 2011] - PubMed result
ncbi.nlm.nih.gov — “PubMed is a service of the U.S. National Library of Medicine that includes over 19 million citations from MEDLINE and other life science journals for biomedical articles back to the 1950s. PubMed includes links to full text articles and other related resources.” View full resource at ncbi.nlm.nih.gov
Most Recently Shared on August 9, 2011 at 11:39 pm By:
G Garcia-Manero Internist, Oncologist, Physician, and Doctor
http://www.ncbi.nlm.nih.gov/pubmed/21653939 High early death in patients with acute promyelocytic leukemia. This... http://fb.me/QwpgxZ0z
CytRx's Tamibarotene Eradicates Cancer in Advanced Acute Promyelocytic Leukemia After Failure of Other Therapies - FierceBiotech
fiercebiotech.com — “CytRx's Tamibarotene Eradicates Cancer in Advanced Acute Promyelocytic Leukemia After Failure of Other TherapiesTamibarotene-Treated Leukemia Patient Achieves Molecular Complete Remission Following Read more...” View full resource at fiercebiotech.com
Most Recently Shared on July 23, 2010 at 1:26 am By:
CytRx's tamibarotene eradicates cancer in advanced acute promyelocytic leukemia after failure of other therapies. http://bit.ly/9z7AoH
Clinical significance of CD56 expression in patients with acute promyelocytic leukemia treated with all-trans retinoic acid and anthracycline-based regimens
bloodjournal.hematologylibrary.org — “Clinical significance of CD56 expression in patients with acute promyelocytic leukemia treated with all-trans retinoic acid and anthracycline-based regimens” View full resource at bloodjournal.hematologylibrary.org
Most Recently Shared on February 22, 2011 at 1:47 am By:
G Garcia-Manero Internist, Oncologist, Physician, and Doctor
CD56 as a marker of prognosis in APL... http://fb.me/HCLtJOvt
Prospective Minimal Residual Disease Monitoring to Predict Relapse of Acute Promyelocytic Leukemia and to Direct Pre-Emptive Arsenic Trioxide Therapy - OncologySTAT
oncologystat.com — “J Clin Oncol. 2009 Jun 6; Epub ahead of print - MRD assessment by real-time qualitative PCR, combined with preemptive arsenic trioxide, markedly improved relapse rates.” View full resource at oncologystat.com
Most Recently Shared on June 24, 2009 at 8:57 pm By:
OncologySTAT Health Site and Oncology
Story of the Week: Preemptive Therapy Based on Real-Time Quantitative PCR Improves Relapse-Free Survival in APL http://tinyurl.com/nqmp7v
Nursing Article | Leukemia
mdlinx.com — “Acute Promyelocytic Leukemia: An Overview With Implications for Oncology Nurses” View full resource at mdlinx.com
Most Recently Shared on December 8, 2010 at 8:02 am By:
Sandeep Pulim MD Doctor, Health Communicator, and Physician
Acute Promyelocytic Leukemia: An Overview With Implications for Oncology Nurses: Clinical Journal of On... http://bit.ly/dRm4iN #Nursing
Oncology Article | Leukemia
mdlinx.com — “Phase II study of single-agent arsenic trioxide for the front-line therapy of acute promyelocytic leukemia” View full resource at mdlinx.com
Most Recently Shared on June 17, 2011 at 9:23 am By:
Sandeep Pulim MD Doctor, Health Communicator, and Physician
Phase II study of single-agent arsenic trioxide for the front-line therapy of acute promyelocytic leuk... http://bit.ly/mDdLrP #oncology
Acute Lymphoblastic Leukemia (ALL)
kidshealth.org — “ALL is the most common type of leukemia, affecting nearly 60% of kids who have this cancer of the blood cells. With treatment, most recover.” View full resource at kidshealth.org
Most Recently Shared on December 31, 2010 at 12:15 am By:
Pediatrics Medical News about Leukemia
mdlinx.com — “External Auditory Canal and Middle Ear Relapse of Acute Promyelocytic Leukemia Treated With Arsenic Trioxide” View full resource at mdlinx.com
Most Recently Shared on April 13, 2010 at 2:44 am By:
Sandeep Pulim MD Doctor, Health Communicator, and Physician
External Auditory Canal and Middle Ear Relapse of Acute Promyelocytic Leukemia Treated With Arsenic Trioxide:... http://bit.ly/aNLwza #peds
ENT Medical News about Leukemia
mdlinx.com — “External Auditory Canal and Middle Ear Relapse of Acute Promyelocytic Leukemia Treated With Arsenic Trioxide” View full resource at mdlinx.com
Most Recently Shared on April 12, 2010 at 5:57 pm By:
Sandeep Pulim MD Doctor, Health Communicator, and Physician
External Auditory Canal and Middle Ear Relapse of Acute Promyelocytic Leukemia Treated With Arsenic Tr... http://bit.ly/dD0BXt #ENT #mdlinx
The Top 3 resources shared on this topic. More resources.
Key stats and trends about this topic
Related WisdomCards
Related Health Centers
Featuring the top 3 experts for this topic
-
NewsRx Medical News
-
Neurology Journal
-
Sandeep Pulim MD
Over 2K medical journal articles & health news summarized and delivered FREE to 35 specialties daily. Oncology, Rheumatology, Cardiology, Neurology, Psychiatry
Advertisement
